Skip to content
Inciteful Med

Standard Treatment: The Crucial Role of Colchicine

Last updated:

Daily colchicine is the gold standard treatment for Familial Mediterranean Fever (FMF). Taking it every day is essential to prevent painful flare-ups and protect your organs from AA amyloidosis by keeping silent inflammation and Serum Amyloid A (SAA) levels low.

Key Takeaways

  • • Colchicine is a daily preventive medication that stops or significantly reduces FMF attacks in about 90% of patients.
  • • Taking colchicine every day is crucial to prevent silent inflammation and life-threatening organ damage known as AA amyloidosis.
  • • Common stomach side effects can often be managed by splitting the dose, adjusting your diet, or slowly increasing the medication amount.
  • • You must avoid grapefruit entirely and be cautious with certain antibiotics, like clarithromycin, to prevent dangerous colchicine toxicity.
  • • If colchicine is ineffective or poorly tolerated, biologic medications like IL-1 blockers are available as highly effective alternatives.

Colchicine is the cornerstone of life with Familial Mediterranean Fever (FMF). Often called the “gold standard” treatment, it has been used for decades to transform a condition of chronic pain into a manageable, long-term health plan [1][2]. For approximately 90% of patients, daily colchicine either completely stops attacks or significantly reduces how often and how severe they are [3][4].

Why “Daily” Means Every Single Day

The most important thing to understand about colchicine is that its job isn’t just to stop the pain you feel today; it is to protect your organs for the future [2][5].

  • Preventing the “Silent” Fire: Even when you don’t have a fever or pain, FMF can cause “subclinical” or silent inflammation in your body [6][7].
  • The Amyloidosis Shield: If left unchecked, this silent inflammation causes a protein called Serum Amyloid A (SAA) to build up in your organs, particularly the kidneys [8][9]. This can lead to a life-threatening condition called AA amyloidosis [9][5]. Daily colchicine is the most effective way to keep SAA levels low and prevent this damage [2][1].
  • The Risk of Skipping: Missing even a few doses can allow inflammation to flare up again, increasing the risk of a breakthrough attack or the gradual buildup of amyloid proteins [10][11].

Managing Side Effects

The most common reason patients struggle with colchicine is gastrointestinal (GI) upset, such as diarrhea, nausea, or abdominal cramping [12][13]. These side effects are often dose-related and can frequently be managed without stopping the medication:

  1. Split the Dose: Instead of taking one large dose, your doctor may suggest taking smaller amounts several times a day [14].
  2. Dietary Adjustments: Some patients find that a temporary low-lactose or low-fat diet helps settle the stomach while their body adjusts to the medication [12][15].
  3. Start Low, Go Slow: Doctors often start with a small dose and gradually increase it to find the “sweet spot” where inflammation is controlled but side effects are minimal [12].

Important Safety Warnings

While colchicine is very safe when taken as prescribed, there are a few critical safety rules:

  • Drug Interactions: Medications like certain antibiotics (especially clarithromycin) or certain heart medications can cause colchicine to build up to toxic levels in your blood [16][17]. Always tell every doctor you see that you take daily colchicine [18].
  • Dietary Warnings: You must avoid grapefruit and grapefruit juice entirely while taking colchicine. Grapefruit blocks the enzyme your body uses to clear the medication, which can quickly lead to dangerous or even fatal toxicity [18].
  • Pregnancy and Breastfeeding: Because FMF affects young people, a major concern is whether colchicine is safe during pregnancy. Medical consensus strongly dictates that continuing colchicine during pregnancy and breastfeeding is crucial. FMF flares and the risk of amyloidosis are far more dangerous to both the mother and the baby than the medication itself [19][20].
  • Not for Acute Relief: While colchicine is sometimes used to treat acute attacks of gout, in FMF it is strictly for prevention. Taking extra colchicine during an active FMF flare will not stop the attack and only increases your risk of side effects [21].

If you find that you cannot tolerate colchicine or if your attacks continue despite a full dose, modern “biologic” medications (such as IL-1 blockers) are available as highly effective alternatives [22][1].

Frequently Asked Questions

Why do I need to take colchicine every day for FMF?
Daily colchicine prevents both painful flare-ups and silent inflammation between attacks. Skipping doses increases your risk of sudden attacks and a dangerous protein buildup in your organs called amyloidosis.
Will taking extra colchicine help stop an active FMF flare?
No, colchicine is strictly for preventing attacks in FMF. Taking extra colchicine during an active flare will not stop the pain and only increases your risk of gastrointestinal side effects and toxicity.
What should I do if colchicine hurts my stomach?
Gastrointestinal side effects like diarrhea or nausea are common but can often be managed. Your doctor may suggest splitting your daily amount into smaller doses, starting with a lower dose, or trying a temporary low-lactose diet.
Can I eat grapefruit or drink grapefruit juice while taking colchicine?
You must completely avoid grapefruit and grapefruit juice while taking this medication. Grapefruit blocks the enzyme your body uses to clear the drug, which can quickly lead to dangerous and potentially fatal toxicity.
Is it safe to take colchicine for FMF during pregnancy?
Yes, medical consensus states that continuing colchicine during pregnancy and breastfeeding is crucial. Uncontrolled FMF flares and the risk of amyloidosis are far more dangerous to both the mother and the baby than the medication itself.
What happens if colchicine doesn't work for my FMF?
If you continue to have attacks or cannot tolerate the side effects despite dosage adjustments, your doctor may discuss modern biologic medications, such as IL-1 blockers, which are highly effective alternatives.

Questions for Your Doctor

  • • Is my current colchicine dose effectively suppressing 'silent' inflammation between my attacks?
  • • Can we check my Serum Amyloid A (SAA) levels to ensure I am protected against amyloidosis?
  • • If I experience diarrhea, should I try a low-lactose diet or split my dose before considering a dose reduction?
  • • Are any of my other medications, specifically antibiotics like clarithromycin, dangerous to take with colchicine?
  • • If I continue to have attacks while taking colchicine daily, at what point should we discuss switching to an IL-1 blocker?

Questions for You

  • • Do I ever skip my colchicine dose when I've been feeling well for a long time?
  • • Have I noticed any patterns with my stomach issues—do they happen right after I take my medication?
  • • Am I tracking my 'minor' symptoms (like joint aches or fatigue) even when I don't have a full fever?
  • • How does my quality of life change when I am strictly adherent to my daily medication compared to when I am not?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [Familial mediterranean fever].

    Vinit C

    La Revue du praticien 2023; (73(8)):843-849.

    PMID: 38354004
  2. 2

    Familial Mediterranean Fever.

    Ozdogan H, Ugurlu S

    Presse medicale (Paris, France : 1983) 2019; (48(1 Pt 2)):e61-e76 doi:10.1016/j.lpm.2018.08.014.

    PMID: 30686512
  3. 3

    [INTERLEUKIN 1 INHIBITORS--A NEW HORIZON IN THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER].

    Shouval R, Livneh A, Ben-Zvi I

    Harefuah 2015; (154(11)):716-9, 741.

    PMID: 26821505
  4. 4

    Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series.

    Sendogan DO, Saritas H, Kumru G, et al.

    Transplantation proceedings 2019; (51(7)):2292-2294 doi:10.1016/j.transproceed.2019.03.049.

    PMID: 31400972
  5. 5

    Familial Mediterranean fever-associated renal amyloidosis: case report and review of the literature.

    Andronesi AG, Ismail G, Gherghiceanu M, et al.

    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2019; (60(4)):1299-1303.

    PMID: 32239108
  6. 6

    Cardiac disease in familial Mediterranean fever.

    Erken E, Erken E

    Rheumatology international 2018; (38(1)):51-58 doi:10.1007/s00296-017-3853-8.

    PMID: 29051974
  7. 7

    Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever.

    Lofty HM, Marzouk H, Farag Y, et al.

    International journal of rheumatology 2016; (2016()):7354018 doi:10.1155/2016/7354018.

    PMID: 28070191
  8. 8

    Unraveling the genome: Familial Mediterranean fever.

    Koehler AW

    Journal of the American Association of Nurse Practitioners 2024; (36(1)):3-5 doi:10.1097/JXX.0000000000000959.

    PMID: 38165779
  9. 9

    Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever.

    Siligato R, Gembillo G, Calabrese V, et al.

    Medicina (Kaunas, Lithuania) 2021; (57(10)) doi:10.3390/medicina57101049.

    PMID: 34684086
  10. 10

    Discontinuation of Colchicine Therapy in Children With Familial Mediterranean Fever.

    Aviel YB, Rawan S, Fahoum S, et al.

    The Journal of rheumatology 2021; (48(11)):1732-1735 doi:10.3899/jrheum.201158.

    PMID: 33993110
  11. 11

    Colchicine treatment can be discontinued in a selected group of pediatric FMF patients.

    Cohen K, Spielman S, Semo-Oz R, et al.

    Pediatric rheumatology online journal 2023; (21(1)):2 doi:10.1186/s12969-022-00780-w.

    PMID: 36600239
  12. 12

    Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials.

    Andreis A, Imazio M, Avondo S, et al.

    Journal of cardiovascular medicine (Hagerstown, Md.) 2021; (22(8)):637-644 doi:10.2459/JCM.0000000000001157.

    PMID: 33399344
  13. 13

    Clinical Manifestations and Outcomes of Colchicine Poisoning Cases; a Cross Sectional Study.

    Rahimi M, Alizadeh R, Hassanian-Moghaddam H, et al.

    Archives of academic emergency medicine 2020; (8(1)):e53.

    PMID: 32440664
  14. 14

    Interventions for reducing inflammation in familial Mediterranean fever.

    Yin X, Tian F, Wu B, Xu T

    The Cochrane database of systematic reviews 2022; (3()):CD010893 doi:10.1002/14651858.CD010893.pub4.

    PMID: 35349164
  15. 15

    Effect of Low-dose ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Low Dose Trial.

    Tabbalat RA, Alhaddad I, Hammoudeh A, et al.

    The Journal of international medical research 2020; (48(7)):300060520939832 doi:10.1177/0300060520939832.

    PMID: 32720823
  16. 16

    Examining the Characteristics of Colchicine-Induced Myelosuppression in Clinical Cases: A Systematic Review.

    Sim BL, Sim BZ, Tunbridge M, et al.

    The Journal of rheumatology 2023; (50(3)):400-407 doi:10.3899/jrheum.220524.

    PMID: 36319015
  17. 17

    Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.

    Haj Yahia S, Ben Zvi I, Livneh A

    Rheumatology international 2018; (38(1)):141-147 doi:10.1007/s00296-017-3823-1.

    PMID: 28975396
  18. 18

    Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.

    Cohen O, Locketz G, Hershko AY, et al.

    Rheumatology international 2015; (35(11)):1937-41 doi:10.1007/s00296-015-3325-y.

    PMID: 26210999
  19. 19

    Fertility in male patients with familial Mediterranean fever and paternal effect of FMF on pregnancy outcomes and complications.

    Parlar K, Azman FN, Sıcakyüz SL, et al.

    Internal and emergency medicine 2025; (20(3)):797-803 doi:10.1007/s11739-025-03881-y.

    PMID: 39907917
  20. 20

    Familial Mediterranean Fever Is Associated With Increased Mortality After Kidney Transplantation-A 19 Years' Single Center Experience.

    Green H, Lichtenberg S, Rahamimov R, et al.

    Transplantation 2017; (101(10)):2621-2626 doi:10.1097/TP.0000000000001681.

    PMID: 28926523
  21. 21

    Familial Mediterranean fever, review of the literature.

    Alghamdi M

    Clinical rheumatology 2017; (36(8)):1707-1713 doi:10.1007/s10067-017-3715-5.

    PMID: 28624931
  22. 22

    Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.

    Yildirim T, Yilmaz R, Uzerk Kibar M, Erdem Y

    Journal of nephrology 2018; (31(3)):453-455 doi:10.1007/s40620-018-0475-5.

    PMID: 29446001

This page explains colchicine treatment for Familial Mediterranean Fever (FMF) for educational purposes. Always consult your rheumatologist or prescribing doctor before adjusting your medication or diet.

Stay up to date

Get notified when new research about Familial Mediterranean fever is published.

No spam. Unsubscribe anytime.